NCT00504946 - Pharmacological Modulations of Allergen-Specific Immunotherapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Asthma

Interventions

DRUG

prednisone, lactose

"Allergen immunotherapy (build-up phase)premedication with orally administrated in the day of immunotherapy:~20mg prednisone+ 0.3mg lactose"

DRUG

prednisone, colecalciferol, lactose

"Allergen immunotherapy (build-up phase)premedication with orally administrated in the day of immunotherapy:~20mg prednisone + 1000j colecalciferol + 0.3mg lactose"

DRUG

lactose

"Allergen immunotherapy (build-up phase)premedication with orally administrated in the day of immunotherapy:~0.3mg lactose"

DRUG

montelukast sodium

Allergen immunotherapy (build-up phase)premedication with montelukast sodium. Children 6-14 years received 5 mg of montelukast and children \> 14 years old received 10mg oral tablet once daily at bedtime

DRUG

lactose

Allergen immunotherapy (build-up phase)premedication with 0,3mg lactose once daily at bedtime

Trial Locations (1)

93-513

Department of Pediatrics and Allergy, Medical University of Lodz Lodz, Poland, Lodz

All Listed Sponsors

lead

Medical University of Lodz

OTHER